Chemical Structure (Viread 01)
Viread Powder
Product Images NDC 61958-0403
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Viread (NDC 61958-0403). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Gilead Sciences, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure A (Viread 02)
Figure B (Viread 03)
Figure C (Viread 04)
Prinicpal Display Panel (300 mg Bottle Label)
Viread tablets contain 150mg of tenofovir disoproxil fumarate which is equivalent to 123mg of tenofovir disoproxil. They should be stored at 25°C (77 °F) and kept tightly closed in the original container. The dosage should be as per the prescribing information. These tablets are manufactured by Gilead Sciences, Inc. and made in Canada. The NDC code for these tablets is 61958-0404-1 and a pack contains 30 tablets.*
Prinicpal Display Panel (150 mg Bottle Label)
Viread tablets contain 200mg of tenofovir disoproxil fumarate or 163mg of tenofovir disoproxil. It is to be stored at 25°C and should only be dispensed in the original container. The usual dosage is not available. It is manufactured by Gilead Sciences, Inc in Canada.*
Prinicpal Display Panel (200 mg Bottle Label)
Viread tablets contain 250mg of tenofovir disoproxil fumarate in each tablet which is equivalent to 204mg, it is advised to keep the container tightly closed and only dispense from the original container. The usual dosage is to be determined by a prescribing physician, and more information is available in the prescribing information insert. The tablets are manufactured for Gilead Sciences, Inc. and come in a container of 30 tablets, with NDC 61958-0406-1. Made in Canada.*
Prinicpal Display Panel (250 mg Bottle Label)
Viread tablets contain 300 mg of Tenofovir disoproxil fumarate, which is equivalent to 245 mg of Tenofovir disoproxil. It is manufactured by Gilead Sciences in Canada and should be stored at 25 °C. The package insert should be consulted for dosage and administration information. Container should be kept tightly closed and dispensed in its original container.*
Prinicpal Display Panel (60 g Bottle Carton)
Viread Oral Powder is a medication manufactured by Gilead Sciences, Inc. that contains 40 mg of tenofovir disoproxil fumarate per scoop. The medication should be stored at 25°C (77°F) and can only be mixed with soft foods. The dosing scoop provided should be used to measure the powder according to the Patient Information included with the medication. No further information on dosage or usage is available.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
